Paracetamol 650mg / Ascorbic acid 50mg oral powder sachets
Shortage warning
Current supply issues
High shortage warning
Healthcare professionals should be aware of the potential for delayed onset of angioedema and the distinction between bradykinin- and histamine-mediated cases, as treatment strategies differ significantly and bradykinin-medi…
Affected areas: UK
Official documents, adverse reaction reporting, and safety monitoring
Report a side effect
Submit a Yellow Card report to the MHRA
Official medicine documents
Safety monitoring data
Yellow Card reports
The MHRA Yellow Card scheme collects reports of suspected side effects from healthcare professionals and patients. View the Drug Analysis Profile (iDAP) for real-world adverse reaction data.
View Drug Analysis Profile
Browse all Drug Analysis Profiles A–Z
Browse all iDAP reports
Interactive Drug Analysis Profiles for all medicines
Report a side effect
Submit a Yellow Card report to the MHRA
Data from the MHRA Yellow Card scheme. A reported reaction does not necessarily mean the medicine caused it. Contains public sector information licensed under the Open Government Licence v3.0.
EudraVigilance
The European Medicines Agency (EMA) collects suspected adverse reaction reports from across the EU/EEA through the EudraVigilance system. Search for safety data on this medicine.
Search EudraVigilance database
Browse substances A–Z in the European adverse reaction database
About EudraVigilance
Learn about EU pharmacovigilance and safety monitoring
EudraVigilance data is published by the European Medicines Agency (EMA). A suspected adverse reaction is not necessarily caused by the medicine.
2 branded products available
Therapeutically similar medicines
Similarity is based on WHO Anatomical Therapeutic Chemical (ATC) classification and on a factual NHS dm+d therapeutic-grouping code prefix. Source data: NHS dm+d via TRUD (OGL v3.0), WHO ATC/DDD Index.
NHS prescribing volume and spending trends
Check stock at pharmacies and supply information
Pharmacy stock checkers
Search for this medicine at major UK pharmacy chains. These links open the retailer's own website — results depend on their current online catalogue.
Supply & safety information
Official UK regulator monitoring and safety alerts
Pharmacy links redirect to the retailer's own search and do not represent real-time stock levels. Shortage and safety information sourced from MHRA drug safety updates (gov.uk, Crown Copyright under OGL v3.0).
Codes for healthcare professionals and prescribing systems
These codes are used by healthcare IT systems and prescribers to identify this medicine.
NHS UK identifiers
Browse tools
SNOMED CT and dm+d codes from NHS TRUD (Technology Reference data Update Distribution), licensed under the Open Government Licence v3.0. BNF code shown is the factual mapping value distributed by NHS Business Services Authority (NHSBSA) in the dm+d supplementary file under OGL v3.0; it is not affiliated with, nor licensed from, the publishers of the British National Formulary. ATC codes from the WHO Collaborating Centre for Drug Statistics Methodology (whocc.no).
Active and completed clinical studies from ClinicalTrials.gov
Source: ClinicalTrials.gov, a database of the U.S. National Library of Medicine (NLM), National Institutes of Health (NIH). Data accessed via ClinicalTrials.gov API v2. Trial information is provided for research purposes and does not constitute medical advice.
Academic studies and reviews for this medicine's active substance
Showing all 26 studies.
Randomised trials: 1 · 2018–2026
Showing all 26 studies, sorted by most relevant.
Nussbaumer-Pröll A, Hausmann B, Weber M, et al.
2025
Background: The collection of microorganisms that colonize the human genital and urinary tract is referred to as the genitourinary microbiome. Urinary tract infections (UTIs), which predominantly affect women, are linked to alterations in the genitourinary microbiome. Cranberries (Vaccinium oxycoccos), rich in proanthocyanidins, and ascorbic acid (vitamin C), known for their urinary acidification properties, are commonly used for UTI prevention. However, their effects on the genitourinary microbiome remain inadequately characterized. This pilot study assesses the genitourinary microbiome composition in healthy women and evaluates the influence of cranberry and ascorbic acid supplementation. Methods: In a randomized, controlled, and open-label trial, 27 healthy women in their reproductive age (18–40 years) were assigned to three groups: cranberry (n = 8), ascorbic acid (n = 10), and control (n = 9). Urine samples were collected at three time points and processed for 16S rRNA gene amplicon-based microbial community composition analysis. Microbiome composition was compared within and between groups, and between study visits. Results: Sufficient microbial DNA was extracted from all midstream urine samples. The genitourinary microbiome was predominantly composed of Lactobacillus spp., as reported previously. No significant shifts in microbial composition were observed in response to cranberry or ascorbic acid supplementation, and no statistically significant differences were detected between the intervention and control groups or between study visits. Conclusion: The genitourinary microbiome of healthy women remained stable during cranberry or ascorbic acid supplementation. Further studies in patients with recurrent UTIs are needed to explore the potential impacts of these supplements on the genitourinary microbiome in disease states.
Abstract licence: CC BY
Fatima Zahra Makhlouf, M. L. Chelaghmia, R. Kihal, et al.
Microchemical Journal, 2024
Aya A. Mouhamed, B. Eltanany, Nadia M Mostafa, et al.
Journal of chromatographic science, 2024
- Acetaminophen
- Ascorbic Acid
- Caffeine
Sara M. Eltabey, Ali H. Ibrahim, Mahmoud M. Zaky, et al.
Current Issues in Molecular Biology, 2024
Escherichia coli is a major cause of serious infections, with antibiotic resistance rendering many treatments ineffective. Hence, novel strategies to combat this pathogen are needed. Anti-virulence therapy is a promising new approach for the subsequent era. Recent research has examined the impact of sub-inhibitory doses of ascorbic acid and paracetamol on Escherichia coli virulence factors. This study evaluated biofilm formation, protease production, motility behavior, serum resistance, expression of virulence-regulating genes (using RT-PCR), and survival rates in a mouse model. Ascorbic acid significantly reduced biofilm formation, protease production, motility, and serum resistance from 100% in untreated isolates to 22–89%, 10–89%, 2–57%, and 31–35% in treated isolates, respectively. Paracetamol also reduced these factors from 100% in untreated isolates to 16–76%, 1–43%, 16–38%, and 31–35%, respectively. Both drugs significantly down-regulated virulence-regulating genes papC, fimH, ompT_m, stcE, fliC, and kpsMTII. Mice treated with these drugs had a 100% survival rate compared with 60% in the positive control group control inoculated with untreated bacteria. This study highlights the potential of ascorbic acid and paracetamol as anti-virulence agents, suggesting their use as adjunct therapies alongside conventional antimicrobials or as alternative treatments for resistant Escherichia coli infections.
Abstract licence: CC BY
Eda M. A. Alshailabi, O. A. Abdalally, F. Mohammed
Al-Kitab Journal for Pure Sciences, 2024
Ascorbic acid (AA) plays roles in many biological functions, such as participating in the production of collagen by taking a role in proline and lysine hydroxylation. AA works by removing the reactive oxygen species, thus removing the adhesion of neutrophils to endothelium. The present study investigates the protective effects of AA on the testis tissue damage induced by paracetamol in rats. Thirty-two male rats were equally divided into four groups, with eight rats in each. Group (1) regular control group, group (2) was received 500 mg/kg/b.w. of AA orally for two weeks, group (3) was received 500 mg/kg/b.w. of paracetamol orally for two weeks, group (4) was treated with the AA (500 mg/kg/b.w.) and paracetamol (500 mg/kg/b.w.) orally for two weeks. The histopathological investigations of the testis tissues from the paracetamol group showed atrophy and degeneration of seminiferous tubules with an absence of spermatozoa, presence of cell debris, and loss of the Sertoli cells in some seminiferous tubules when compared with control animals. The testis tissues from a protective group showed less damage in the tubules and germ cells when compared with the paracetamol group. This study indicates that AA protects against paracetamol-induced testis damage in adult male rats.
Abstract licence: CC BY
Udi, O. A., Moronkeji, A., Nwaokoro, I. C., et al.
Asian Journal of Research in Medical and Pharmaceutical Sciences, 2024
Guzide Pekcan
Journal of Pharmaceutical Research Science & Technology, 2025
Bosnali W, Korkmaz Ş, Mülazımoğlu AD, et al.
2025
A simple, facile, and sensitive method based on leather shaving waste extract (LSWE) modified pencil graphite electrode (PGE) was developed to determine paracetamol (PAR) by employing the square wave adsorptive stripping voltammetry (SW-AdSV) technique. Leather shaving waste (LSW) was characterized by energy-dispersive X-ray spectroscopy and by investigating its morphology by taking scanning electron microscopy (SEM) images. The extraction process was conducted on an LSW by utilizing acetonitrile. Furthermore, the extraction ratio of LSW to acetonitrile was optimized and found to be 0.1 g LSW/10 mL acetonitrile at room temperature for an extraction period of 12 h. Modification of PGE by 0.1 g of LSWE (0.1LSWE/PGE) was done by performing cyclic voltammetry (CV) at the potential range 0–(+2.3) V for 10 cycles, followed by a characterization process of 0.1LSWE/PGE by employing CV, electrochemical impedance spectroscopy, and SEM techniques. PAR determination parameters at 0.1LSWE/PGE were optimized and found to be an accumulation time of 35 s in Britton Robinson buffer solution at pH 1.8. A linear relationship (r2 = 0.997) was observed between peak current and PAR concentration within the range 5–100 μM, with a sensitivity of 196.46 μA μM–1 cm–2. The limit of detection and limit of quantification were found to be 1.6 and 4.51 μM, respectively. Neglected interferant influence on the determination of PAR at 0.1LSWE/PGE was observed in the presence of dopamine, uric acid, caffeine, ascorbic acid, Na+, K+, Mg2+, Ca2+, NO3–, and Cl– ions. In order to evaluate 0.1LSWE/PGE in the determination of PAR in real pharmaceutical samples, different common PAR-containing pharmaceuticals in Türkiye were analyzed, achieving a recovery range of 99.76–102.87%.
Abstract licence: CC BY
Nur Tasnim Adlina Mazdi, Nur Aisyah Mior Mat Zin, Muhammad Aiman Khairul Hisham, et al.
Drug Development and Industrial Pharmacy, 2025
- Acetaminophen
- Ascorbic Acid
- Chemistry, Pharmaceutical
Irmer E
2025
The study of crystallography and the introduction to X-ray structure analysis are generally regarded as tasks for universities and, even then, usually only in graduate studies. However, analysis of crystal structures in science classes at high schools offers a wide range of opportunities for illustrating and improving understanding of fundamental structural chemistry concepts. This article attempts to share some experiences with crystallographers who want to work with high school students on crystallographic topics. After presenting some preconditions for introducing students to crystallographic topics, such as the curricular situation, two levels of didactical reduction are suggested. Examples of the use of database structures from the Protein Data Bank and the Teaching Subset of the Cambridge Structural Database in chemistry lessons are presented. In the Göttingen experimental laboratory for young people, XLAB, high school students can carry out the essential steps of structure determination, structure solution and refinement of X-ray diffraction data themselves, using aspirin or citric acid as examples. Finally, a network scheme for promoting crystallographic topics in the classroom is proposed.
Abstract licence: CC BY
Sources: aggregated from Europe PMC (EMBL-EBI), OpenAlex, Crossref, PubMed and other open scholarly databases. Retracted articles are excluded. Study information is provided for research purposes and does not constitute medical advice.
Structured knowledge from the free knowledge base
ATC classifications (Wikidata)
Linked open data from Wikidata (Q113839210), a free and open knowledge base operated by the Wikimedia Foundation. Data is available under the Creative Commons CC0 1.0 Public Domain Dedication.
Scientific data (pharmacology, interactions, ADME) is not yet available for this medicine. Clinical sections are sourced from the NHS dm+d database.